Page last updated: 2024-09-05

sb 203580 and cephalotaxine

sb 203580 has been researched along with cephalotaxine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(cephalotaxine)
Trials
(cephalotaxine)
Recent Studies (post-2010) (cephalotaxine)
3,48941,137705

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)cephalotaxine (IC50)
Mitogen-activated protein kinase 13Homo sapiens (human)0.2
Mitogen-activated protein kinase 12Homo sapiens (human)0.2
Mitogen-activated protein kinase 11Homo sapiens (human)0.2
Mitogen-activated protein kinase 14Homo sapiens (human)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clutter, MR; Crane, JM; Krutzik, PO; Nolan, GP1

Other Studies

1 other study(ies) available for sb 203580 and cephalotaxine

ArticleYear
High-content single-cell drug screening with phosphospecific flow cytometry.
    Nature chemical biology, 2008, Volume: 4, Issue:2

    Topics: Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Janus Kinases; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Phosphorus; Sensitivity and Specificity; Signal Transduction; STAT Transcription Factors

2008